ALCON NORDIC A/S: Financial statements 2014
CVR: 15887478
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ALCON NORDIC A/S (CVR 15887478) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 197,612,000 and a net result of DKK 21,995,000 compared with DKK 8,676,000 the year before. That is an increase of 94.1% compared with the year before. Equity in the 2014 report amounted to DKK 40,082,000. The solvency ratio was 12.4%. The company had 49 employees in the financial year.
- Gross Profit
- DKK 197,612,000
- Profit/Loss
- DKK 21,995,000
- Equity
- DKK 40,082,000
- Total Assets
- DKK 322,964,000
- Employees
- 49
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 197.6M | 22M | 40.1M | 49 |
| 2013 | - | 101.8M | 8.7M | 13.8M | 32 |
| 2012 | - | 50.7M | 4.3M | 15.1M | 49 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
ALCON NORDIC A/S has published its annual report for 2013. Gross profit came to DKK 101,796,000, and the net result was DKK 8,676,000.
As of May 2, 2014, Riad Sherif has joined the board of directors of ALCON NORDIC A/S.
As of May 2, 2014, Stuart Raetzman has left the board of directors of ALCON NORDIC A/S.
On January 1, 2014, the company changed its name from ALCON DANMARK A/S to ALCON NORDIC A/S.
About ALCON NORDIC A/S
ALCON NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 1992. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ALCON DANMARK A/S and ALCON DANMARK ApS. The management consists of Petr Kotelnikov. The board consists of Julien Rosentraub (chair), Petr Kotelnikov and Umut Meric. The company is owned by Alcon Pharmaceuticals Ltd. The company has 75 employees (2026). In 2025, the company reported revenue of DKK 1,060,222,000 and a net result of DKK 42,026,000 compared with DKK 34,391,000 the year before. Equity in the 2025 report amounted to DKK 171,120,000.